Artwork

Content provided by The Wall Street Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Wall Street Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Trillion Dollar Shot, Episode 1: Birth of a Blockbuster

41:36
 
Share
 

Manage episode 417969684 series 3208963
Content provided by The Wall Street Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Wall Street Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Before Ozempic, Wegovy, Mounjaro and Zepbound, there was Lotte Bjerre Knudsen.

In the 1990s, the young scientist at the Danish drug company Novo Nordisk was trying to unlock the key to a new technology for treating Type 2 diabetes. To her bosses, Lotte’s project, which focused on a hormone called GLP-1, looked like a distraction.

But as Lotte fought to save her diabetes project from the chopping block, she couldn’t have imagined how much of an impact her breakthrough would have. Her work would pave the way for a hit drug called Ozempic. And it would unleash a new class of blockbuster drugs, pitting two companies in a race to become the world’s first trillion-dollar pharmaceutical company by market cap.

Listen to Part 1 of “Trillion Dollar Shot” now.

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

1220 episodes

Artwork
iconShare
 
Manage episode 417969684 series 3208963
Content provided by The Wall Street Journal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Wall Street Journal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Before Ozempic, Wegovy, Mounjaro and Zepbound, there was Lotte Bjerre Knudsen.

In the 1990s, the young scientist at the Danish drug company Novo Nordisk was trying to unlock the key to a new technology for treating Type 2 diabetes. To her bosses, Lotte’s project, which focused on a hormone called GLP-1, looked like a distraction.

But as Lotte fought to save her diabetes project from the chopping block, she couldn’t have imagined how much of an impact her breakthrough would have. Her work would pave the way for a hit drug called Ozempic. And it would unleash a new class of blockbuster drugs, pitting two companies in a race to become the world’s first trillion-dollar pharmaceutical company by market cap.

Listen to Part 1 of “Trillion Dollar Shot” now.

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

1220 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide